GB2489275A - Breathing device - Google Patents
Breathing device Download PDFInfo
- Publication number
- GB2489275A GB2489275A GB1104927.7A GB201104927A GB2489275A GB 2489275 A GB2489275 A GB 2489275A GB 201104927 A GB201104927 A GB 201104927A GB 2489275 A GB2489275 A GB 2489275A
- Authority
- GB
- United Kingdom
- Prior art keywords
- tube length
- airway
- nasal
- airway tube
- management device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000029058 respiratory gaseous exchange Effects 0.000 title description 8
- 201000002859 sleep apnea Diseases 0.000 claims abstract description 8
- 210000003928 nasal cavity Anatomy 0.000 claims abstract description 7
- 230000000414 obstructive effect Effects 0.000 claims abstract description 7
- 210000001584 soft palate Anatomy 0.000 claims description 13
- 229920000642 polymer Polymers 0.000 claims description 8
- 210000001331 nose Anatomy 0.000 claims description 6
- 229920001084 poly(chloroprene) Polymers 0.000 claims description 5
- 229920002379 silicone rubber Polymers 0.000 claims description 3
- 239000004945 silicone rubber Substances 0.000 claims description 2
- 238000004873 anchoring Methods 0.000 abstract description 2
- 210000001519 tissue Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000003437 trachea Anatomy 0.000 description 3
- 206010041235 Snoring Diseases 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229920003051 synthetic elastomer Polymers 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000000884 Airway Obstruction Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010016946 Food allergy Diseases 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000032109 Transient ischaemic attack Diseases 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 208000008784 apnea Diseases 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000003300 oropharynx Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000023516 stroke disease Diseases 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 201000010875 transient cerebral ischemia Diseases 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/04—Tracheal tubes
- A61M16/0461—Nasoendotracheal tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/56—Devices for preventing snoring
- A61F5/566—Intra-oral devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/06—Respiratory or anaesthetic masks
- A61M16/0666—Nasal cannulas or tubing
Landscapes
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Otolaryngology (AREA)
- Nursing (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Abstract
The present invention provides an airway management device suitable for use by sufferers of obstructive sleep apnoea and which comprises a bifurcated airway body having a first nasal airway tube length 1a and a second nasal airway tube length 1b and a bridging portion 1c, the first nasal airway tube length 1a and the second nasal airway tube length 1b being adapted to extend from a proximal end thereof seated externally at the entrance of a respective one of the user's nostrils through the nasal cavity to a distal end thereof opening into the oro-pharyngeal region of the user's mouth, the bridging portion 1c linking together the proximal ends of the first nasal airway tube length 1a and the second nasal airway tube length 1b, which may be flared F for a more secure fit. The device not only has a greater airflow but also is inherently more stable and secure than existing naso-pharyngeal airway devices. Overall the device is not liable to dislodgement when sleeping and does not require use of any special anchoring arrangements at each end.
Description
Breathing Devices
Field of the Invention
The present invention concerns improvements in and relating to breathing devices and in particular airway management devices for use by sufferers of obstructive sleep apnoea (O.S.A.) to prevent the condition or alleviate the symptoms.
Background of the Invention
Obstructive sleep apnoea is a widespread medical condition that affects over a million individuals in the UK alone. In the condition, which is often exacerbated by obesity, a common cause is loss of muscle tone in the throat & oral tissues, particularly the soft palate, whereby the individual's breathing is interrupted and becomes very shallow during sleep. The breathing pauses can typically last between 10 and 20 seconds and can occur hundreds of times during a night. In extreme cases this can be lethal and even in mild cases will tend to cause fatigue and can lead to depression, diabetes, high blood pressure, transient ischemic attacks (TIA's), stroke and heart disease.
The traditional radical solution to address O.S.A entails surgery on the tissues of the airway obstruction to ablate them or improve muscle tone. However, more recently various orthodontic or mandibular devices have become available, designed primarily to alleviate snoring and these are generally adapted to be inserted in the mouth and function by mandibular advancement -pulling the tongue forwards and thereby opening the throat slightly improving ventilation of the superior airway but having no effect on the soft palate or nasal airways. These are not a comfortable or effective solution to O.S.A.
A particularly commonly prescribed modern treatment for O.S.A. entails use of a continuous positive airway pressure (C.P.A.P.) machine to ventilate the user's airways. The treatment involves fitting a mask to a patient's face to supply pressurised air to the nose and! or mouth of the patient from a pump machine at the patient's bedside. The air pressure is regulated to suit the individual user. While the use of C.P.A.P. produces an immediate improvement in sleep quality, the mask and the necessity of its being attached to the machine, is cumbersome & restricts movement during sleep. Due to apparatus cost, size and safety issues the C.P.A.P treatment is unsuited for widespread domestic use.
More recently others have developed devices that are simpler to manufacture and use, lightweight and compact and which are designed to be inserted into the nasal passageway. These are primarily known as naso-pharyngeal airway devices and an example of these is shown in POT W0201 0/113305. However, such devices tend comprise relatively hard plastics or rubber single tubes that tend to be somewhat unstable when fitted and in use unless anchored at one or both ends. In POT W0201 0/113305 it is proposed to have a ring at each end and optionally a balloon at the oro-pharyngeal end, whereas in US2O1O/0300450 the device has an inflatable supra-glottic laryngeal cuff. In such cases the device can only be safely fitted in place by a surgeon or by trained medical personnel, not self-administered.
It is an objective of the present invention to provide an airway management device suitable for use by sufferers of obstructive sleep apnoea (O.S.A.) and which has the simple to manufacture and use, lightweight and compact merits of the current naso-pharyngeal airway devices but which provides enhanced airflow, better stability while being readily self-administered.
Summary of the Invention
According to a first aspect of the present invention there is provided an airway management device suitable for use by sufferers of obstructive sleep apnoea and which comprises a bifurcated airway body having a first nasal airway tube length and a second nasal airway tube length and a bridging portion, the first nasal airway tube length and the second nasal airway tube length being adapted to extend from a proximal end thereof seated externally at a mouth of a respective one of the user's nostrils through the nasal cavity to a distal end thereof opening into the oro-pharyngeal region of the user's mouth, the bridging portion linking together the proximal ends of the first nasal airway tube length and the second nasal airway tube length.
Preferably the bridging portion is thickened so that it is prominent relative to the proximal ends of the airway lengths to pass as a robust bridge over the septum of the nose while the proximal ends of the airway lengths remain approximately flush with the nostrils. The bridging portion is suitably of the order of 3mm thick or greater.
Because the device is bifurcated as described it thereby not only has a greater airflow but also is inherently more stable and secure than existing naso-pharyngeal airway devices. Overall the device is not liable to dislodgement when sleeping and does not require use of any special anchoring arrangements at each end.
Nevertheless, preferably the external ends of first nasal airway tube length and the second nasal airway tube length of the device are not only joined together by the bridging portion but also are each flared. Though the device is efficiently anchored against entry into the nasal passages by the existence of the bridging portion, the additional use of flared proximal ends of the tube lengths has the particular benefit of stopping any substantial airflow from passing around each tube length. This has been found to be particularly useful since we have found that otherwise the peripheral airflow can cause irritation of the nasal tissues and induce streams of mucus.
The first nasal airway tube length and the second nasal airway tube length are preferably both configured with an inherent curvature and which most preferably is in a shallow or flattened arc. The first nasal airway tube length and the second nasal airway tube length are suitably configured to extend substantially parallel to each other throughout their length whereby the device is substantially axi-symmetric and preferably are spaced apart by no more than about 5mm. Also it is preferred that the internal diameter of each of the nasal airway tube lengths is 5mm, or of the order of 4mm to 6mm.
Preferably the tubular wall of each airway tube length is of an elastomeric polymer that is 2mm or less and most preferably of the order of 1 mm thick, whereby the tube remains soft and flexible for comfortable fitting and wearing but retains sufficient rigidity of tubular form that it will not be collapsed by irregular soft tissue formations of the nasal cavity or soft palate or localized vascular dilation and airway muscular constriction but will retain integrity as an airway. Presently preferred elastomeric polymers include silicone rubber and polychloroprene.
Suitably the external diameter of the distal end of each nasal airway tube length is of the order of 7mm where the internal diameter is 5mm. With flaring, external diameter of the proximal end of each nasal airway tube length is suitably of the order of double or more the external diameter of the distal end of each nasal airway tube length. In one preferred embodiment the external diameter of the flared proximal end is of the order of 18mm.
With minimal instruction the device of the present invention may be inserted by the user into his or her nasal cavities to reach through to just below the soft palate.
Unlike naso-tracheal cannulae that are fitted to hospital patients for assisted breathing during anaesthesia et cetera, the present device is relatively short and also relatively soft. it suitably reaches to just below the soft palate but not lower to the laryngeal inlet of the trachea (unlike the many laryngeal cuff terminated devices of the prior art) nor does it extend into the trachea. It does not obstruct the trachea or oro-pharyngeal tract and is also not liable to twist and kink as the patient turns their neck.
The device is relatively soft and does not have the same level of tube reinforcement! tubular rigidity as naso-tracheal cannulae. Indeed it can generally be softer than existing naso-pharyngeal airway devices because it is bifurcated and thereby has greater airflow and is inherently more stable and secure than the existing naso-pharyngeal airway devices.
The softness of the device presents minimal risk of any tissue trauma/abrasion during installation and in use. As a result of these advantageous features the device can be readily self-administered, rather than requiring insertion by a surgeon or by trained medical personnel.
In a practical embodiment, that we have found to be suitable for an average adult male, the length of the device from end to end may be of the order of 160mm. The thickness of the tubular body is preferably of the order of 2mm at most and without need of any wire reinforcement or use of special strengthening polymers. Clear silicone or polychloroprene polymers are currently preferred alternative polymers from which the device may be moulded.
As the tubular lengths of the device pass through to the underside of the soft palate, they restrict vibration or movement of the soft palate. With the device in place, normal breathing through the nose is possible with the airway remaining unobstructed and the subject can move freely during sleep without fear of dislodging the device.
Brief Description of the Drawings
The invention will now be more particularly described, solely by way of example, with reference to the accompanying drawings in which: Figure 1 is a front elevation view of an airway management device of the present invention; Figure 2 is a side elevation view of the device; Figure 3 is a longitudinal sectional view of the device showing the airway passage through the device; and Figure 4 is a schematic sectional view of a user's head showing the device in situ extending through the user's nasal cavity to just beyond the soft palate and thus providing for unimpeded airflow to and from the oro-pharynx.
Description of the Preferred Embodiment
Referring to the Figures, the preferred embodiment of the device is formed as a one piece moulding from an elastomer such as latex or more preferably a synthetic elastomer such as silicone or polychloroprene (a synthetic elastomer with similar attributes to natural rubber but without the associated danger of Type I protein allergies).
Both silicone elastomer and polychloroprene are suitable for injection moulding, the most practical & cost efficient process for the manufacture of this device. Both materials are suitably soft and pliable for this application and can withstand high temperatures (up to 137° C) for the purpose of sterilisation by hot water. Flushing with hot water and rinsing in baby bottle sterilising fluid are recommended after each use. These materials, in clear! transparent form, will make apparent any deposits in the tubes.
The device comprises a bifurcated airway body 1 having a first nasal airway tube length la and a second nasal airway tube length lb and a bridging portion Ic. The first nasal airway tube length Ia and the second nasal airway tube length lb are adapted to extend from a proximal end that seats at the external entrance to a respective one of the user's nostrils through the nasal cavity to a distal end opening into the oro-pharyngeal region of the user's mouth. The bridging portion lc links together the proximal ends of the first nasal airway tube length and the second nasal airway tube length and is thickened so that it is prominent relative to the proximal ends of the airway lengths. It forms a robust bridge over the septum of the user's nose while the proximal ends of the airway lengths remain approximately flush with the nostrils. The bridging portion is of the order of 3mm thick or greater.
The external proximal ends of first nasal airway tube length Ia and the second nasal airway tube length lb of the device 1 are not only joined together by the bridging portion Ic but also are each flared F. The flared proximal ends F provide a snug fit in the nostrils and allow easy unassisted normal breathing without inhaled or exhaled air bypassing the airway tubes of the device, which can create irritation.
The nose is the normal and natural entry point to the respiratory tract and the device of the present invention is designed specifically for the prevention or amelioration of sleep apnoea by fitting into the nostrils and with the airway lengths of the device passing to just beyond the soft palate to thereby provide a direct uninhibited airway to the major respiratory tract. The device can be inserted by the user with minimal instruction, a small amount of lubricating gel is recommended. Coughing and swallowing are not affected by the device which is unobtrusive and allows the user complete freedom of movement during sleep.
For a first fitting of the device the user may have it cut to a tailored size by a professional or may follow provided instructions to do so. In practice it is desirable to take a standard size of the device and tailor it to an individual by cutting off a portion of the airway lengths at the distal end. In some cases the trimming may also apply to the flared proximal ends too in order to render them as flush-fitting as possible. After the first fitting the user will not need any assistance to install the device in place for a good night's sleep.
In summary, the device I comprises a pair of gently curved soft elastomeric tubes I a, lb that are flared at one end and at that end joined lc at the top innermost edges.
The whole device is moulded in one piece. On fitting, the tubes Ib, Ic are inserted into the nostrils and, being curved, naturally follow the path through the nasal passages over the soft palate into the top of the throat to just below the bottom skirt of the soft palate, thus preventing the soft palate moving! blocking the nasal passages on exhalation ( apnoea) or vibrating (snoring). The bridging portion lc holds the whole device securely in place.
Claims (14)
- Claims 1. An airway management device suitable for use by sufferers of obstructive sleep apnoea and which comprises a bifurcated airway body having a first nasal airway tube length and a second nasal airway tube length and a bridging portion, the first nasal airway tube length and the second nasal airway tube length being adapted to extend from a proximal end thereof seated externally at the entrance of a respective one of the user's nostrils through the nasal cavity to a distal end thereof opening into the oro-pharyngeal region of the user's mouth, the bridging portion linking together the proximal ends of the first nasal airway tube length and the second nasal airway tube length.
- 2. An airway management device according to claim 1, wherein the bridging portion is thickened so that it is prominent relative to the proximal ends of the airway lengths to pass as a robust bridge over the septum of the nose while the proximal ends of the airway lengths remain approximately flush with the nostrils..
- 3. An airway management device according to claim I or 2, wherein the external ends of first nasal airway tube length and the second nasal airway tube length of the device are not only joined together by the bridging portion but also are each flared.
- 4. An airway management device according to claim 1, 2 or 3, wherein the first nasal airway tube length and the second nasal airway tube length are each configured with an inherent curvature.
- 5. An airway management device according to claim 1, 2, 3 or 4, wherein the device is substantially axi-symmetric, the first nasal airway tube length and the second nasal airway tube length extending substantially parallel to each other throughout their length.
- 6. An airway management device according to any preceding claim, wherein the first nasal airway tube length and the second nasal airway tube length are spaced apart by no more than about 5mm.
- 7. An airway management device according to any preceding claim, wherein the internal diameter of each of the nasal airway tube lengths is of the order of 4mm to 6mm.
- 8. An airway management device according to any preceding claim, wherein the tubular wall of each airway tube length is of an elastomeric polymer that is 2mm or less thick.
- 9. An airway management device according to any preceding claim, wherein the tubular wall of each airway tube length is of an elastomeric polymer selected from silicone rubber and polychloroprene.
- 10. An airway management device according to claim 3, wherein with the flaring, the external diameter of the proximal end of each nasal airway tube length is of the order of double or more the external diameter of the distal end of each nasal airway tube length.
- 11 An airway management device according to any preceding claim and in use, wherein the device reaches to just below the soft palate of the user.
- 12 An airway management device according to any preceding claim, wherein the length of the device from end to end is of the order of 140mm to 170mm.
- 13. An airway management device according to any preceding claim, wherein the device is of a substantially transparent polymer.
- 14. An airway management device suitable for use by sufferers of obstructive sleep apnoea substantially as hereinbefore described with reference to the accompanying drawings.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1104927.7A GB2489275A (en) | 2011-03-24 | 2011-03-24 | Breathing device |
PCT/GB2012/000270 WO2012127193A1 (en) | 2011-03-24 | 2012-03-26 | Breathing device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1104927.7A GB2489275A (en) | 2011-03-24 | 2011-03-24 | Breathing device |
Publications (2)
Publication Number | Publication Date |
---|---|
GB201104927D0 GB201104927D0 (en) | 2011-05-04 |
GB2489275A true GB2489275A (en) | 2012-09-26 |
Family
ID=44013063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1104927.7A Withdrawn GB2489275A (en) | 2011-03-24 | 2011-03-24 | Breathing device |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB2489275A (en) |
WO (1) | WO2012127193A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3856310A4 (en) * | 2018-09-24 | 2022-06-22 | NPA Medical, LLC | Nasopharyngeal airway device |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017079885A (en) * | 2015-10-23 | 2017-05-18 | 信越ポリマー株式会社 | Clip for nasal cavity insertion tube and nasal cavity insertion tube having the same |
GB2611304B (en) * | 2021-09-29 | 2023-10-04 | Clairvo Lesley | Sleep apnoea device |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3867946A (en) * | 1973-10-29 | 1975-02-25 | Robert A Huddy | Binasopharyngeal airway |
US20060048775A1 (en) * | 2004-09-09 | 2006-03-09 | Dunlap Ivan L | Nasopharyngeal airway device and method of use |
US20080236591A1 (en) * | 2007-04-02 | 2008-10-02 | Georges Boussignac | Respiratory probe |
US20090248058A1 (en) * | 2008-04-01 | 2009-10-01 | Robert Kotler | Device and Method for Maintaining Unobstructed Nasal Passageways after Nasal Surgery |
WO2010113305A1 (en) * | 2009-04-01 | 2010-10-07 | 株式会社アイ.エス.テイ | Tube for resolving obstructive sleep apnea syndrome |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL119693A0 (en) * | 1996-11-26 | 1997-02-18 | Roman Gindis | Intranasal snore preventing device |
KR20090022709A (en) * | 2007-08-31 | 2009-03-04 | 신상승 | Prosthesis for preventing snoring and the method for preventing snoring |
US20100300450A1 (en) | 2009-05-28 | 2010-12-02 | The Johns Hopkins University | Nasal airway management device with inflatable supraglottic laryngeal cuff |
-
2011
- 2011-03-24 GB GB1104927.7A patent/GB2489275A/en not_active Withdrawn
-
2012
- 2012-03-26 WO PCT/GB2012/000270 patent/WO2012127193A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3867946A (en) * | 1973-10-29 | 1975-02-25 | Robert A Huddy | Binasopharyngeal airway |
US20060048775A1 (en) * | 2004-09-09 | 2006-03-09 | Dunlap Ivan L | Nasopharyngeal airway device and method of use |
US20080236591A1 (en) * | 2007-04-02 | 2008-10-02 | Georges Boussignac | Respiratory probe |
US20090248058A1 (en) * | 2008-04-01 | 2009-10-01 | Robert Kotler | Device and Method for Maintaining Unobstructed Nasal Passageways after Nasal Surgery |
WO2010113305A1 (en) * | 2009-04-01 | 2010-10-07 | 株式会社アイ.エス.テイ | Tube for resolving obstructive sleep apnea syndrome |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3856310A4 (en) * | 2018-09-24 | 2022-06-22 | NPA Medical, LLC | Nasopharyngeal airway device |
Also Published As
Publication number | Publication date |
---|---|
GB201104927D0 (en) | 2011-05-04 |
WO2012127193A1 (en) | 2012-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2697439C (en) | Laryngeal mask | |
CN106488784B (en) | Patient interface for respiratory therapy | |
US8833373B2 (en) | Nasally inserted airway opening device for obstructive sleep apnea treatment | |
US20020124849A1 (en) | Nasal breathing mask with adjustable thermistor for treating respiratory disorders of sleep | |
JPH09505211A (en) | Oralopharyngeal ventilation tube with sleeve | |
JP2007518451A (en) | Inhalation therapy system including a nasal cannula assembly | |
CN112437653B (en) | Oral appliance | |
KR101686747B1 (en) | Appliance for snoring prevention | |
AU2015230679A1 (en) | Improved laryngeal mask | |
US9962283B2 (en) | Aid for supporting of jaw angle used against snoring and sleep apnea | |
AU2013234867B2 (en) | Devices for maintaining an oropharyngeal airway, methods of creating an oropharyngeal airway and systems for maintaining an oropharyngeal airway | |
US20150230969A1 (en) | Nasopharyngeal Device for Obstructive Sleep Apnea Syndrome | |
KR20000068452A (en) | Device for preventing snoring and apnoea during sleep | |
US20030084905A1 (en) | Tracheostomy tube with cuff on inner cannula | |
WO2019162024A1 (en) | Snorkel ventilating airway and bite-block | |
GB2489275A (en) | Breathing device | |
KR101828841B1 (en) | Apparatus for general snoring prevention | |
US10286172B1 (en) | Epiglottis avoidance airway | |
Greenberg | Facemask, nasal, and oral airway devices | |
CN209500028U (en) | Nasopharynx bracket for snore relieving | |
KR20090022709A (en) | Prosthesis for preventing snoring and the method for preventing snoring | |
WO2019195579A1 (en) | Mouth shield device for treatment of dry mouth, teeth grinding, snoring, and sleep apnea and methods of use thereof | |
CN209500027U (en) | Nasopharynx bracket for snore relieving | |
CN219847722U (en) | Silica gel false chin for respirator mask | |
US11918502B2 (en) | Bi-flow nasal stent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |